Skip to main content

Table 1 Correlation between kallistatin expression and clinicopathologic parameters

From: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer

Parameters nKallistatin expressionP value
Low (n = 144)High (n = 168)
Age(years)< 5514958910.0170*
≥551638677
FIGO stageI + II6021390.0614
III + IV250122128
CA125 (U/ml)< 60012257650.6745
≥6001747797
Ascites (ml)< 100016567980.0432*
≥10001467670
PlatinumResistant9130150.0127*
Sensitive454051
Omentum metastasisPositive1031011080.2081
Negative2094261
Lymph node metastasisPositive7229270.2546
Negative563042
RecurrenceNo8129520.0156*
Yes1819487